胰腺导管腺癌(pancreatic ductal ...

A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic ...

引言在与癌症的博弈中，胰腺导管腺癌（Pancreatic Ductal Adenocarcinoma, ...

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related mortality worldwide. Current treatment modalities are few or ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit writes about the critical federal funding at risk and what this ...

PDAC, an aggressive and often difficult-to-diagnose cancer, frequently spreads before detection. The study, published in the ...

The study demonstrates that PAC-MANN-1 outperforms the widely used CA 19-9 biomarker, offering greater accuracy in detecting all stages of PDAC. The assay is particularly promising for identifying ...

The trial’s first phase will begin in university hospitals across the Netherlands, Denmark, Germany and Sweden.

Scientists suggest understanding ecDNA’s role in pancreatic cancer could potentially guide future strategies for making ...

Encouraging preclinical data supporting the use of DNase-based technology to target NETosis and address difficult to treat cancers ...

Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced positive results from the VERIFI study, the second clinical validation study of its next-generation ...